News

News

Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary...

March 22, 2007 — Evalve, Inc., a privately held medical device company, has announced the FDA has approved a registry of up to 70 patients who are at high risk of mortality from surgical treatment...

March 12, 2007 — FORTUNE Magazine has named St. Jude Medical Inc. one of “America’s Most Admired Companies” for 2007. St. Jude Medical ranked No. 1 in the Medical Products and Equipment Companies...